These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 9051244

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
    Mehta J, Kelsey S, Chu P, Powles R, Hazel D, Riley U, Evans C, Newland A, Treleaven J, Singhal S.
    Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254
    [Abstract] [Full Text] [Related]

  • 3. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM, Lumbreras C, González-Vidal D, Grupo de Farmacovigilancia de Abelcet.
    Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
    [Abstract] [Full Text] [Related]

  • 4. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD, Dodds Ashley ES, Addison RM, Alspaugh JA, Chao NJ, Perfect JR.
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [Abstract] [Full Text] [Related]

  • 5. Study of renal safety in amphotericin B lipid complex-treated patients.
    Alexander BD, Wingard JR.
    Clin Infect Dis; 2005 May 01; 40 Suppl 6():S414-21. PubMed ID: 15809928
    [Abstract] [Full Text] [Related]

  • 6. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
    Noskin G, Pietrelli L, Gurwith M, Bowden R.
    Bone Marrow Transplant; 1999 Apr 01; 23(7):697-703. PubMed ID: 10218847
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Ito JI, Chandrasekar PH, Hooshmand-Rad R.
    Bone Marrow Transplant; 2005 Nov 01; 36(10):873-7. PubMed ID: 16113663
    [Abstract] [Full Text] [Related]

  • 8. Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
    Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, Hiemenz J, Chanock SJ.
    Pediatr Infect Dis J; 1999 Aug 01; 18(8):702-8. PubMed ID: 10462340
    [Abstract] [Full Text] [Related]

  • 9. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
    Perfect JR.
    Clin Infect Dis; 2005 May 01; 40 Suppl 6():S401-8. PubMed ID: 15809926
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM, Seibel NL, Walsh TJ.
    Pediatr Infect Dis J; 2005 Feb 01; 24(2):167-74. PubMed ID: 15702047
    [Abstract] [Full Text] [Related]

  • 11. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
    Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RH, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS.
    Clin Infect Dis; 1996 Feb 01; 22(2):315-21. PubMed ID: 8838189
    [Abstract] [Full Text] [Related]

  • 12. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
    Hooshmand-Rad R, Reed MD, Chu A, Gotz V, Morris JA, Weinberg J, Dominguez EA.
    Clin Ther; 2004 Oct 01; 26(10):1652-62. PubMed ID: 15598482
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.
    Linden P, Williams P, Chan KM.
    Clin Transplant; 2000 Aug 01; 14(4 Pt 1):329-39. PubMed ID: 10945204
    [Abstract] [Full Text] [Related]

  • 14. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
    Chandrasekar PH, Ito JI.
    Clin Infect Dis; 2005 May 01; 40 Suppl 6():S392-400. PubMed ID: 15809925
    [Abstract] [Full Text] [Related]

  • 15. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.
    Eur J Haematol; 2004 May 01; 72(5):342-7. PubMed ID: 15059069
    [Abstract] [Full Text] [Related]

  • 16. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S, Ellis RW, Jones SG, Miller SJ, Fisher NC, Hastings JG, Mutimer DJ.
    Liver Transpl; 2000 Sep 01; 6(5):588-95. PubMed ID: 10980058
    [Abstract] [Full Text] [Related]

  • 17. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
    López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, Arribas JR, Salas A, Laguna F, Sust M, Cañavate C, Alvar J, Spanish HIV-Leishmania Study Group.
    J Antimicrob Chemother; 2004 Mar 01; 53(3):540-3. PubMed ID: 14739148
    [Abstract] [Full Text] [Related]

  • 18. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review.
    Rowles DM, Fraser SL.
    Clin Infect Dis; 1999 Dec 01; 29(6):1564-5. PubMed ID: 10585814
    [Abstract] [Full Text] [Related]

  • 19. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II.
    Cancer; 2008 Mar 15; 112(6):1282-7. PubMed ID: 18224662
    [Abstract] [Full Text] [Related]

  • 20. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
    Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ.
    Clin Infect Dis; 1998 Jun 15; 26(6):1383-96. PubMed ID: 9636868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.